Biomarkers of response to omalizumab in patients with chronic spontaneous urticaria.
Baseline total IgE may predict omalizumab response, while ANA and anti-TG positivity correlate with delayed response. Elevated TSH and CRP levels may indicate a higher recurrence risk after treatment discontinuation.
Authors
- Esra Nur Bülbül (ORCID: https://orcid.org/0000-0001-8777-9368)
- Şadan Soyyiğit (ORCID: https://orcid.org/0000-0003-3270-5884)
- Neyran Şerbetçi (ORCID: https://orcid.org/0000-0002-9612-2373)
- Zeynep Çelebi Sözener (ORCID: https://orcid.org/0000-0003-4188-0959)
- Esra İnan
- Özge Öztürk Aktaş (ORCID: https://orcid.org/0000-0002-1939-2636)
- Şengül Beyaz
- Begüm Görgülü Akın (ORCID: https://orcid.org/0000-0002-6200-0909)
- Dilek Öksüzer Çimşir
- Türkan Zeynep Fendoğlu
Institutions
- Ankara University (TR)
- Bilkent University (TR)
- Başkent University Hospital (TR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.15586/aei.v53i4.1343
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00